Aperture Investors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Hold |
63,804
| – | – | 0.57% | 49 |
|
|
2025
Q1 | $4.43M | Buy |
63,804
+9,344
| +17% | +$649K | 0.57% | 47 |
|
|
2024
Q4 | $4.68M | Hold |
54,460
| – | – | 0.59% | 45 |
|
|
2024
Q3 | $6.48M | Hold |
54,460
| – | – | 0.82% | 35 |
|
|
2024
Q2 | $7.77M | Hold |
54,460
| – | – | 1.14% | 31 |
|
|
2024
Q1 | $6.99M | Buy |
54,460
+22,842
| +72% | +$2.93M | 0.9% | 40 |
|
|
2023
Q4 | $3.27M | Sell |
31,618
-30,534
| -49% | -$3.16M | 0.58% | 46 |
|
|
2023
Q3 | $5.65M | Sell |
62,152
-4,788
| -7% | -$435K | 0.9% | 35 |
|
|
2023
Q2 | $5.42M | Hold |
66,940
| – | – | 0.64% | 42 |
|
|
2023
Q1 | $5.33M | Buy |
66,940
+10,208
| +18% | +$812K | 0.74% | 37 |
|
|
2022
Q4 | $3.84M | Sell |
56,732
-22,050
| -28% | -$1.49M | 0.63% | 40 |
|
|
2022
Q3 | $3.93M | Buy |
78,782
+53,410
| +211% | +$2.66M | 0.64% | 41 |
|
|
2022
Q2 | $1.41M | Buy |
+25,372
| New | +$1.41M | 0.24% | 55 |
|